PMDA drug package insert
プロイメンド点滴静注用150mg
PMDA Prescription drug · 小野薬品工業株式会社 · package insert Dec 11, 2023
Key facts
| Brand names | プロイメンド点滴静注用150mg |
|---|---|
| Nonproprietary names | ホスアプレピタントメグルミン |
| Companies | 製造販売／小野薬品工業株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 選択的NK1受容体拮抗型制吐剤 |
| Therapeutic category codes | 872391 |
| YJ codes | 2391405D1020 |
| Approval numbers | 22300AMX01211000 |
| Package insert edition | 第2版 |
| Package insert date | Dec 11, 2023 |
| PMDA document key | 180188_2391405D1020_1 |
| PMDA company code | 180188 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: